Grunenthal Acquires Global Rights for Qutenza(R)
AACHEN, Germany , Nov. 5, 2018 /PRNewswire-AsiaNet/ -- Grunenthal, the science-focused pharmaceutical company based in Germany, announced today that it has acquired additional global commercial rights for the dermal pain patch Qutenza(R) (8% capsaicin) from Acorda Therapeutics, Inc (USA). Grunenthal i...
Read more https://view-release/?pr-id=76118